Published in Ophthalmology on August 15, 2011
Multicenter Uveitis Steroid Treatment (MUST) Trial (MUST) | NCT00132691
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51
Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population. Ophthalmol Ther (2014) 1.20
Systemic therapies for inflammatory eye disease: past, present and future. BMC Ophthalmol (2013) 1.12
Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol (2013) 1.02
Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology (2013) 1.02
Sustained-release corticosteroid options. J Ophthalmol (2014) 0.99
Inhibition of neovascularization but not fibrosis with the fluocinolone acetonide implant in autosomal dominant neovascular inflammatory vitreoretinopathy. Arch Ophthalmol (2012) 0.99
Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res (2012) 0.99
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials. Clin Trials (2011) 0.97
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology (2012) 0.97
Local therapies for inflammatory eye disease in translation: past, present and future. BMC Ophthalmol (2013) 0.97
Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy. Clin Ophthalmol (2013) 0.95
The future of uveitis treatment. Ophthalmology (2013) 0.92
Nanotechnology and nanotoxicology in retinopathy. Int J Mol Sci (2011) 0.92
A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology (2014) 0.88
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology (2014) 0.88
Success with single-agent immunosuppression for multifocal choroidopathies. Am J Ophthalmol (2014) 0.86
Surgical management in patient with uveitis. Indian J Ophthalmol (2013) 0.84
Intravitreal devices for the treatment of vitreous inflammation. Mediators Inflamm (2012) 0.83
Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Ophthalmology (2015) 0.82
Postoperative outcomes after fluocinolone acetonide implant surgery in patients with birdshot chorioretinitis and other types of posterior and panuveitis. Retina (2013) 0.82
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology (2014) 0.81
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy. Dtsch Arztebl Int (2012) 0.81
Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Am J Ophthalmol (2015) 0.81
Fundus image diagnostic agreement in uveitis utilizing free and open source software. Can J Ophthalmol (2013) 0.81
Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis (2015) 0.81
Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study. Ophthalmol Ther (2015) 0.79
Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis. Graefes Arch Clin Exp Ophthalmol (2015) 0.79
Review of Systemic Immunosuppression for Autoimmune Uveitis. Ophthalmol Ther (2014) 0.78
Drug delivery implants in the treatment of vitreous inflammation. Mediators Inflamm (2013) 0.78
The transitioning from trials to extended follow-up studies. Clin Trials (2014) 0.77
Uveitis and gender: the course of uveitis in pregnancy. J Ophthalmol (2014) 0.77
Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst Rev (2016) 0.77
Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data. Ophthalmic Epidemiol (2013) 0.77
Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye. Med Hypothesis Discov Innov Ophthalmol (2013) 0.77
Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Am J Ophthalmol (2015) 0.77
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014]. Ophthalmologe (2014) 0.76
Birdshot retinochoroidopathy. J Ophthalmic Vis Res (2015) 0.76
Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis. J Ophthalmic Inflamm Infect (2012) 0.76
Remission of Intermediate Uveitis: Incidence and Predictive Factors. Am J Ophthalmol (2016) 0.75
Management of noninfectious posterior uveitis with intravitreal drug therapy. Clin Ophthalmol (2016) 0.75
Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study. Invest Ophthalmol Vis Sci (2015) 0.75
Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis. Acta Ophthalmol (2016) 0.75
Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol (2015) 0.75
Clinical trials in noninfectious uveitis. Int Ophthalmol Clin (2015) 0.75
Uveitic Macular Edema: Treatment Update. Curr Ophthalmol Rep (2016) 0.75
OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT. Retina (2016) 0.75
Novel biomarkers for patients with idiopathic acute anterior uveitis: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Int J Ophthalmol (2017) 0.75
Fluocinolone Implant Forceps: Instrument Modification for Enhanced Implant Insertion. Int Ophthalmol Clin (2016) 0.75
Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention. Taiwan J Ophthalmol (2015) 0.75
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. Ophthalmology (2017) 0.75
An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis. Curr Treatm Opt Rheumatol (2017) 0.75
Ocular sarcoidosis: new diagnostic modalities and treatment. Curr Opin Pulm Med (2017) 0.75
Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Pegaptanib for neovascular age-related macular degeneration. N Engl J Med (2004) 12.01
Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (2001) 10.35
The RAND-36 measure of health-related quality of life. Ann Med (2001) 5.26
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol (1987) 5.13
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol (1996) 3.67
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes (2007) 3.66
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol (2008) 3.14
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. Ophthalmology (2001) 3.12
Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res (1994) 2.68
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum. Ophthalmology (1996) 2.36
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology (2006) 2.35
Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol (2007) 2.18
Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol (2004) 2.11
Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci (2009) 1.88
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol (2010) 1.83
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81
Uveitis: a potentially blinding disease. Ophthalmologica (2004) 1.80
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology (2000) 1.70
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol (2007) 1.66
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology (2010) 1.34
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology (2005) 1.32
Causes of blindness in The Netherlands. Doc Ophthalmol (1982) 1.29
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Comparing significance and magnitude of glaucomatous visual field defects using the SITA and Full Threshold strategies. Acta Ophthalmol Scand (1999) 1.08
Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) (2009) 0.84
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med (2003) 5.88
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect (2005) 3.92
Assessing the implementation of the chronic care model in quality improvement collaboratives. Health Serv Res (2005) 3.51
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40
Uncertainty in Rank Estimation: Implications for Value-Added Modeling Accountability Systems. J Educ Behav Stat (2002) 2.84
Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. J Immunother (2013) 2.80
Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol (2005) 2.79
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology (2004) 2.63
Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology (2002) 2.45
Do patient consent procedures affect participation rates in health services research? Med Care (2002) 2.38
Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Evaluation of patients with scleritis for systemic disease. Ophthalmology (2004) 2.22
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum (2005) 2.03
Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res (2008) 1.99
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Independent but coordinated trials: insights from the practice-based Opportunities for Weight Reduction Trials Collaborative Research Group. Clin Trials (2010) 1.93
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol (2014) 1.88
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol (2010) 1.83
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res (2011) 1.78
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med (2005) 1.75
Quantifying uncertainty in genotype calls. Bioinformatics (2009) 1.74
Measuring the effectiveness of a collaborative for quality improvement in pediatric asthma care: does implementing the chronic care model improve processes and outcomes of care? Ambul Pediatr (2005) 1.72
Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea (2009) 1.69
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology (2007) 1.68
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol (2007) 1.66
Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol (2009) 1.66
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum (2006) 1.64
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol (2010) 1.60
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol (2012) 1.57
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer (2014) 1.55
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology (2010) 1.54
Models for Value-Added Modeling of Teacher Effects. J Educ Behav Stat (2004) 1.54
The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol (2004) 1.52
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51
Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol (2007) 1.50
Analysis of repeated pregnancy outcomes. Stat Methods Med Res (2006) 1.48
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol (2002) 1.48
Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol (2008) 1.47
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology (2008) 1.46
Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology (2005) 1.46
Feasibility of retinoids for the treatment of emphysema study. Chest (2006) 1.45
Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology (2006) 1.45
Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44
Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol (2006) 1.43
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
Variation in quality of diabetes care at the levels of patient, physician, and clinic. Prev Chronic Dis (2007) 1.39
Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Improving the reporting of clinical case series. Am J Ophthalmol (2005) 1.36
Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina (2007) 1.34
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol (2009) 1.33
Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol (2004) 1.32
Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS One (2012) 1.32
Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol (2005) 1.31
Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med (2005) 1.30